Ranolazine: A Better Understanding of Its Pathophysiology and Patient Profile to Guide Treatment of Chronic Stable Angina
Open Access
- 29 November 2021
- journal article
- review article
- Published by Taylor & Francis in Future Cardiology
- Vol. 18 (3) , 235-251
Abstract
Chronic stable angina pectoris, the most prevalent symptomatic manifestation of coronary artery disease, greatly impairs quality of life and is associated with an increased risk for adverse cardiov... Lay abstract Advances in the diagnosis and treatment of diseases of the coronary arteries (the vessels that provide oxygen and nutrients to the heart) have greatly reduced the mortality of heart at...Keywords
Funding Information
- Menarini Group
This publication has 74 references indexed in Scilit:
- Ranolazine Reduces Patient-Reported Angina Severity and Frequency and Improves Quality of Life in Selected Patients with Chronic AnginaDrugs in R&D, 2013
- Effect of Ranolazine on A1C and Glucose Levels in Hyperglycemic Patients With Non-ST Elevation Acute Coronary SyndromeDiabetes Care, 2010
- Effects of Ranolazine on Disease-Specific Health Status and Quality of Life Among Patients With Acute Coronary SyndromesCirculation: Cardiovascular Quality and Outcomes, 2008
- Inhibition of late sodium current to reduce electrical and mechanical dysfunction of ischaemic myocardiumBritish Journal of Pharmacology, 2008
- The cardiac persistent sodium current: an appealing therapeutic target?British Journal of Pharmacology, 2008
- Mechanism of action of the new anti-ischemia drug ranolazineClinical Research in Cardiology, 2007
- Anginal symptoms consistently predict total mortality among outpatients with coronary artery diseaseAmerican Heart Journal, 2003
- ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary articleJACC, 2003
- Long-term nitrate use may be deleterious in ischemic heart disease: A study using the databases from two large-scale postinfarction studiesAmerican Heart Journal, 1999
- Management of Angina PectorisDrugs, 1992